Christopher G. Hayes is CHIEF LEGAL OFFICER of Verrica Pharmaceuticals Inc.. Currently has a direct ownership of 163,226 shares of VRCA, which is worth approximately $1.39 Million. The most recent transaction as insider was on Mar 15, 2024, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 163K
32.46% 3M change
938.73% 12M change
Total Value Held $1.39 Million

Christopher G. Hayes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
BUY
Grant, award, or other acquisition
-
40,000 Added 19.68%
163,226 Common Stock
Nov 15 2023
SELL
Open market or private sale
$34,327 $2.97 p/Share
11,558 Reduced 8.58%
123,226 Common Stock
Nov 14 2023
SELL
Open market or private sale
$64,873 $2.93 p/Share
22,141 Reduced 14.11%
134,784 Common Stock
Aug 24 2023
BUY
Grant, award, or other acquisition
-
75,000 Added 32.34%
156,925 Common Stock
Jul 24 2023
SELL
Open market or private sale
$163,200 $4.83 p/Share
33,789 Reduced 29.2%
81,925 Common Stock
Jul 21 2023
BUY
Grant, award, or other acquisition
-
100,000 Added 46.36%
115,714 Common Stock
Jul 11 2022
BUY
Open market or private purchase
$25,500 $3.4 p/Share
7,500 Added 32.31%
15,714 Common Stock
Jul 05 2022
BUY
Open market or private purchase
$11,999 $2.1 p/Share
5,714 Added 41.03%
8,214 Common Stock
Jun 04 2021
BUY
Open market or private purchase
$24,475 $9.79 p/Share
2,500 Added 50.0%
2,500 Common Stock
CGH

Christopher G. Hayes

CHIEF LEGAL OFFICER
West Chester, PA

Track Institutional and Insider Activities on VRCA

Follow Verrica Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRCA shares.

Notify only if

Insider Trading

Get notified when an Verrica Pharmaceuticals Inc. insider buys or sells VRCA shares.

Notify only if

News

Receive news related to Verrica Pharmaceuticals Inc.

Track Activities on VRCA